SCHEMBL1703545

SCHEMBL1703545

CCCCCCCCCCC(O)C1C=CC2C(=O)N(c3ccccc3)C(=O)C2N1Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PNKP Q96T60 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17019712 1.00 PNKP (1.00) PNKP
SCHEMBL20512281 1.00 PNKP (1.00) PNKP
SCHEMBL22683120 1.00 PNKP (1.00) PNKP
SCHEMBL22000575 1.00 PNKP (1.00) PNKP
SCHEMBL20512279 0.92 PNKP (0.85) PNKP
SCHEMBL22683111 0.91 PNKP (1.00) PNKP
SCHEMBL22683112 0.91 PNKP (1.00) PNKP
Hydrochloric Acid SCHEMBL15348271 0.90 PNKP (0.98) PNKP
Hydrochloric Acid SCHEMBL22683110 0.90 PNKP (0.98) PNKP
SCHEMBL22683117 0.90 PNKP (1.00) PNKP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024186926-A1 STRATEGIES TO PREVENT THE EVOLUTION OF LETHAL, MULTI-THERAPY-RESISTANT, WIDELY METASTATIC CUTANEOUS MELANOMA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-09-12 WO claimed
EP-2635579-B1 SYNTHETIC LETHALITY IN CANCER UNIV ALBERTA (CA) 2020-11-25 EP claimed
EP-3237903-B1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS EXXONMOBIL RES & ENG CO (US) 2020-02-26 EP claimed
EP-3237903-A1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS Exxonmobil Research And Engineering Company (US) 2017-11-01 EP claimed
EP-3237904-A1 METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS Exxonmobil Research And Engineering Company (US) 2017-11-01 EP claimed
US-9694073-B2 Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose) polymerase and uses thereof THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2017-07-04 US claimed
WO-2016106214-A1 METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 WO claimed
WO-2016106211-A1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 WO claimed
US-20160187314-A1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 US claimed
US-20160187315-A1 METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 US claimed
US-20160083732-A1 SYNTHETIC LETHALITY IN CANCER ALBERTA HEALTH SERVICES (CA) 2016-03-24 US claimed
US-20150306219-A1 SMALL MOLECULE INHIBITORS OF POLYNUCLEOTIDE KINASE/PHOSPHATASE, POLY(ADP-RIBOSE) POLYMERASE AND USES THEREOF ALBERTA HEALTH SERVICES (CA) 2015-10-29 US claimed
US-9040551-B2 Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose) polymerase and uses thereof THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2015-05-26 US claimed
US-20130289095-A1 SYNTHETIC LETHALITY IN CANCER THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2013-10-31 US claimed
US-20120142721-A1 SMALL MOLECULE INHIBITORS OF POLYNUCLEOTIDE KINASE/PHOSPHATASE, POLY(ADP-RIBOSE) POLYMERASE AND USES THEREOF ALBERTA HEALTH SERVICES (CA) 2012-06-07 US claimed
EP-2440203-A1 SMALL MOLECULE INHIBITORS OF POLYNUCLEOTIDE KINASE/PHOSPHATASE. POLY(ADP-RIBOSE) POLYMERASE AND USES THEREOF The Governors Of The University Of Alberta (CA) 2012-04-18 EP claimed
WO-2010139069-A1 SMALL MOLECULE INHIBITORS OF POLYNUCLEOTIDE KINASE/PHOSPHATASE. POLY(ADP-RIBOSE) POLYMERASE AND USES THEREOF THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2010-12-09 WO claimed
US-20250257357-A1 TREATMENT OF H3.3-MUTANT BRAIN CANCER WITH PNKP INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2025-08-14 US disclosed
US-20130289095-A1 SYNTHETIC LETHALITY IN CANCER THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2013-10-31 US disclosed
US-20120142721-A1 SMALL MOLECULE INHIBITORS OF POLYNUCLEOTIDE KINASE/PHOSPHATASE, POLY(ADP-RIBOSE) POLYMERASE AND USES THEREOF ALBERTA HEALTH SERVICES (CA) 2012-06-07 US disclosed